Objective. Total knee arthroplasty (TKA) and total hip arthroplasty (THA) are common and effective surgical procedures. This study sought to compare utilization and short-term outcomes of primary TKA and THA in adjacent regions of Canada and the United States.
Methods. The study was designed as a retrospective cohort study of patients who underwent primary TKA or THA, comparing administrative data from New York and Ontario in 2012-2013. Demographic features of the TKA and THA patients, per capita utilization rates, and short-term outcomes were compared between the jurisdictions.
Results. A higher percentage of New York hospitals performed TKA compared to Ontario hospitals (75.7% versus 42.1%; P < 0.001), and the mean annual procedural volume for TKAs was lower in New York hospitals (mean 179 versus 327 in Ontario hospitals; P < 0.001). After direct standardization, utilization was significantly lower in New York compared to Ontario, both for TKA (16.1 TKAs versus 21.4 TKAs per 10,000 population per year; P < 0.001) and for THA (10.5 THAs versus 11.5 THAs per 10,000 population per year; P < 0.001). For those who underwent TKA, the length of stay in Ontario hospitals was significantly longer (mean 3.7 days versus 3.4 days in New York hospitals; P < 0.001). A smaller percentage of New York patients were discharged directly home (46.2% versus 90.9% of Ontario patients; P < 0.001), but 30-day and 90-day readmission rates were higher in New York compared to Ontario (30-day rates, 4.6% versus 3.9% [P < 0.001]; 90-day rates, 8.4% versus 6.7% [P < 0.001]). For the THA cohorts, the results with regard to length of stay, discharge disposition, and readmission rates were similar to those for TKA.
Conclusion. Ontario has higher utilization of total joint arthroplasty than New York but has a smaller percentage of hospitals performing these procedures. Patients are more likely to be discharged home and less likely to be readmitted in Ontario. Our results suggest areas where each jurisdiction could improve.
Primary total knee arthroplasty (TKA) and total hip arthroplasty (THA) are safe and effective treatments
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Supported for patients with advanced arthritis (1, 2) . With an aging population, demand for total joint arthroplasty (TJA [which includes both TKA and THA]) is increasing (3, 4) .
Unlike emergency procedures such as hip fracture repair or percutaneous coronary intervention for ST-segment elevation myocardial infarction, primary TKA and THA are prototypical "preference sensitive" procedures. Patients and providers have considerable discretion over when and whether to proceed with surgery (5). Payors, both public and private, have considerable interest in restraining the utilization of TJA, given that each surgery costs between $10,000 and $20,000 (6, 7) . Most publicly funded health care systems (e.g., Canada, England) use some sort of rationing to limit surgical volumes (8) , often resulting in wait times of 2-12 months (9) . At the same time, government payors face relentless political pressure from patients and physicians to minimize wait times (10) . In comparison, the US uses a relatively laissez faire approach to controlling volumes for most procedures, including TJA. There is a general belief that rates of utilization of most procedures, including TJA, are far higher in the US than in other Organization for Economic Cooperation and Development (OECD) countries (11, 12) , but empirical data are extremely limited (13) (14) (15) .
We used administrative data on primary TKA and THA patients from New York and Ontario to compare the rates of utilization, hospital procedural volumes, and short-term outcomes (length of stay [LOS] , readmission rates, and discharge disposition). We hypothesized that 1) utilization of TJA would be higher in New York compared to Ontario; 2) hospital volumes would be lower in New York; and 3) a greater percentage of Ontario residents would be discharged home after surgery.
PATIENTS AND METHODS
Patient data. New York. We used data from the New York State Inpatient Database (SID) obtained as part of the Agency for Healthcare Research and Quality (AHRQ) Healthcare Cost and Utilization Project (16) . The SID has been used extensively in prior research (17) . Briefly, the SID contains administrative data for all patients in New York admitted to acute care hospitals, excluding small numbers of hospitals operated by the Veterans Administration Health System and certain specialty hospitals such as psychiatric hospitals. Data elements provided by the AHRQ for each admission include patient demographics (age [in years], sex), primary and secondary diagnoses and procedures (coded using International Classification of Diseases, Ninth Revision, Clinical Modification [ICD-9-CM] codes), discharge disposition (e.g., died in hospital, discharged home, post-acute care), a unique patient identifier (used to track patient readmissions over time), and a unique hospital identifier. Comorbid conditions in the SID are captured using algorithms developed by Elixhauser et al (18) .
Ontario. We used Ontario Discharge Abstract Data (DAD) obtained through the Institute for Clinical Evaluative Sciences (ICES). These records provide information on all hospitalizations paid for by the Ontario provincial health insurance plan, which pays for virtually all hospital care provided within the province and provides insurance to all legal residents of Ontario (virtually 100% of the population) (19, 20) . Similar to the SID files, the Ontario DAD provide information regarding patient demographics, primary and secondary diagnoses coded using ICD-10 codes for each hospitalization, discharge disposition, and patient and hospital identifiers. Comorbid conditions were identified using the Quan ICD-10 adaptation of the Elixhauser comorbidity coding scheme (21) .
Cohort generation. We identified adults ages ≥18 years who underwent primary TKA or THA between January 1, 2012 and September 30, 2013, identified based on ICD-9-CM codes 81.54 and 81.51 for the New York SID and Canadian Classification of Intervention codes VG53 and VA53 for the Ontario DAD. Data from September 30 to December 31, 2013 were used for ascertainment of 90-day readmission rates only (22) . We excluded patients who were assigned codes suggestive of trauma or hip fracture, patients whose procedures were performed on an emergent basis (since primary TKA and THA are typically not urgent), patients with a prior TKA or THA within 90 days of the index procedure (because of concern that the second admission could represent a readmission), and patients who underwent ≥2 TKA or THA procedures during the same hospitalization. Inclusion and exclusion criteria were applied to the New York SID and Ontario data using similar methods.
Outcomes. Our study included 4 complementary outcomes: 1) per capita utilization of TKA and THA; 2) hospital LOS; 3) discharge disposition (home versus other); and 4) all-cause hospital readmission occurring within 30 days and 90 days of discharge. After all primary TKA and THA procedures performed in New York and Ontario during the study period were identified, we calculated the annual utilization rates (per 10,000 population). Estimates from the New York population were obtained from US Census data (available at https://www.health.ny.gov/statistics/vital_statistics/2010/table01. htm). Estimates from the Ontario population were obtained from analogous Canadian census data. We linked the New York data to the American Hospital Association annual survey to ascertain information regarding hospital teaching status and bed size. We linked the Ontario DAD to the Ontario Health Insurance Plan Registered Persons Database for mortality information, and to information from the Ontario Ministry of Health and Long-Term Care.
Statistical analysis. All data analyses were conducted separately for the TKA and THA cohorts using similar methods and approaches. First, we compared patient demographics and key comorbid conditions captured during the inpatient hospitalization for patients who underwent TKA in New York and Ontario. We compared continuous measures using the t-test and categorical measures using the chi-square statistic.
Second, using similar bivariate methods, we compared the percentage of hospitals in New York and Ontario performing TKA, the mean and median annual procedural volumes at these hospitals, and the percentage of hospitals performing TKA that were categorized as major teaching hospitals (23) . Similar analyses were performed for the THA cohorts.
Third, we calculated annualized primary TKA utilization rates (number of procedures per 10,000 population per year) for New York and Ontario. The numerator for these calculations was the annualized number of TKA procedures performed between January 1, 2012 and September 30, 2013, while the denominator was the population of adults ages ≥18 years. We calculated utilization for the entire adult population (ages ≥18 years), by age-specific population stratum (e.g., age <50 years, 50-59 years, etc.), and by patient sex (men and women), using analogous numerators and denominators. Similar analyses were performed for the THA cohorts.
We calculated standardized TKA and THA utilization rates for New York using direct standardization, with the Ontario population used as the reference; this allows us to compare utilization in New York and Ontario based on the assumption of similar population demographics in terms of age and sex (24) . We compared utilization of TKA and THA in New York and Ontario using Poisson regression.
Fourth, we compared unadjusted outcomes in the TKA and THA cohorts in New York and Ontario. In particular, we compared the mean hospital LOS, discharge disposition, and hospital readmission rates within 30 days and 90 days of surgery.
Fifth, we examined adjusted outcomes for each study end point, using generalized linear models. We used 3 statistical models for each end point: model 1, adjusted only for patient demographics; model 2, adjusted for demographics plus hospital procedural volume; and model 3, adjusted for all model 2 factors plus comorbid conditions. Comorbid conditions were included in our models based on clinical plausibility and having a reasonable prevalence in both our New York and Ontario populations; of note, because in-hospital mortality was extremely rare, statistical concerns allowed us to include only 2 comorbid conditions related to mortality in model 3.
This analysis was approved by the Research Ethics Board at ICES. All analyses were performed using either SAS or R statistical software packages. (Table 1) .
RESULTS

We
Focusing on TKA, a smaller percentage of procedures in Ontario were performed on patients ages <50 years when compared to those in New York (2.6% versus 5.0%; P < 0.001) ( Table 1) . A smaller percentage of TKAs in Ontario than in New York were performed on women (62.7% versus 65.4%; P < 0.001). The prevalence of all comorbid conditions was significantly lower in Ontario when compared to New York. Findings for THA followed a similar pattern (Table 1) .
Continuing to focus on TKA (Table 2) , a significantly smaller percentage of Ontario hospitals performed TKA when compared to New York hospitals (42.1% versus 75.7%; P < 0.001). Alternatively, the mean annual procedural volume for TKAs in Ontario hospitals was significantly higher than that in New York hospitals (mean 327 versus 179; P < 0.001). Results focusing on THA were similar (Table 2) , with a lower percentage of Ontario hospitals performing the procedure and a higher mean procedural volume for THAs in Ontario.
In analyses using direct standardization, utilization of TKA per 10,000 adults in Ontario was significantly higher (21.4 per 10,000 population per year) as compared to New York (16.1 per 10,000 population per year) (P < 0.001) ( Table 3) . In stratified analyses, utilization of TKA in Ontario was significantly higher for all age strata when compared to New York, with the exception of patients ages <50 years (Table 3) . Utilization of TKA both by women and by men was significantly higher in Ontario compared to New York. Results focusing on THA also showed higher utilization in Ontario when compared to New York, both in aggregate and for most age strata (Table 3) . In unadjusted analyses focusing on outcomes (Table 4) , hospital LOS for TKA was significantly longer in Ontario than in New York (mean 3.7 days versus 3.4 days; P < 0.001), while the frequency of in-hospital mortality among those who underwent TKA was significantly higher in Ontario than in New York, although in terms of clinical significance, this difference was small (frequency of in-hospital mortality 0.07% in Ontario versus 0.03% in New York; P = 0.035).
A significantly higher percentage of Ontario TKA patients as compared to New York TKA patients were discharged home after surgery (90.9% versus 46.2%; P < 0.001). In addition, a lower percentage of Ontario TKA patients compared to New York TKA patients were transferred to another acute-care hospital (0.7% versus 2.8%; P < 0.001). Hospital readmission within 30 days of TKA was lower in Ontario than in New York (3.9% versus 4.6%; P < 0.001); similarly, readmission within 90 days was lower in Ontario as compared to New York (6.7% versus 8.4%; P < 0.001). Analyses focusing on patients who underwent THA revealed that the differences between Ontario and New York were similar to those for TKA for most of the outcomes in unadjusted analyses (Table 4) . In adjusted analyses (adjusted for age, sex, hospital procedural volume, and comorbid conditions) focusing on outcomes in patients who underwent TKA (Table 5) , the frequency of in-hospital mortality in TKA patients was similar between Ontario and New York in all 3 statistical models. The mean hospital LOS for TKA was significantly longer in Ontario than in New York in all 3 models, whereas both 30-day and 90-day readmission rates in TKA patients from Ontario were significantly lower than those from New York. Adjusted analyses focusing on THA patients demonstrated results similar to those for TKA (Table 6 ) (the full regression models with coefficients are shown in Supplementary Tables 1-4 , available on the Arthritis & Rheumatology web site at http://onlinelib rary.wiley.com/doi/10.1002/art.40407/abstract).
DISCUSSION
In this analysis of population-based administrative data, we found that rates of utilization of both TKA and THA were higher in Ontario, Canada as compared to the state of New York. We also found that a smaller percentage of Ontario hospitals performed TJA, and Ontario hospitals had higher surgical volumes compared to New York hospitals. Furthermore, Ontario hospitals appeared to have longer hospital LOS but lower rates of hospital readmissions, and a significantly higher percentage of Ontario residents were discharged home after surgery.
Several of our results warrant elaboration. It is important to consider our TKA and THA utilization data in the context of prior studies of joint arthroplasty utilization. In a prior analysis of US Medicare data (from adults ages ≥65 years), we found primary TKA and THA utilization rates of~60 procedures and~25 procedures per 10,000 population per year, respectively, in 2008-2010 (25-27 ). In the current study, we * TKA = total knee arthroplasty; THA = total hip arthroplasty. * Values are the adjusted proportion experiencing mortality (95% confidence interval), adjusted hospital length of stay (LOS) in days (95% confidence interval), and adjusted percentage experiencing readmission at 30 days and 90 days after initial discharge (95% confidence interval). † Adjusted for patient age and sex. ‡ Adjusted for model 1 factors plus hospital procedural volume. § Adjusted for model 2 factors plus comorbid conditions. UTILIZATION AND OUTCOMES OF THA AND TKA 551 observed utilization rates in our older populations that were roughly similar to those previously reported.
There are very few studies that have directly compared TKA and THA utilization and outcomes between different countries. Pabinger and colleagues used pooled data obtained from the OECD to examine TJA utilization in~20 countries. They found that in 2011, TKA utilization ranged between 2 per 10,000 population (in Poland) and 23 per 10,000 population (in the US) (13) , and THA utilization ranged between 8 per 10,000 population (in Poland) and 29 per 10,000 population (in Germany). We are aware of only one study that directly compared TKA and THA utilization in the US and Canada. In that study, Ravi et al used 2001 Ravi et al used -2007 data from the US Nationwide Inpatient Sample and the province of Ontario; the team found that in 2001, rates of utilization of TKA and THA were~30% and~10% higher, respectively, in the US when compared to Ontario, but differences had declined by 2007 (15) .
Historically, most single-payor health care systems have done relatively well with cost control but have fared poorly with access. The phenomenon of wait lists for elective surgical procedures, including TKA and THA, in Ontario has been well described, as well as the negative impact of wait times on patients' physical function (28, 29) . In the early part of the 21st century, the Canadian government (including Ontario) faced considerable public pressure to improve health care access and reduce wait times, and specifically to improve access to TJA (30, 31) . The government responded with an array of new initiatives and policies. We suspect that these efforts might explain our finding that utilization of TJA in Ontario has now surpassed utilization in New York.
While differences in health care system structures and financing might explain the differences in TJA utilization observed in the present study, there are other potential explanations. It is possible that differences in the prevalence of advanced osteoarthritis or obesity could underlie the differences in TJA utilization, but we are unaware of any convincing data supporting this hypothesis (32) (33) (34) . Another possible explanation for the higher utilization of TJA in Ontario might be that there is a lower threshold for surgery than for medical management in Ontario as compared to New York. Although appropriateness criteria for TJA have been developed (35) (36) (37) , widespread implementation has been limited by the need for detailed clinical, radiographic, and patient-reported symptom scores. Our reliance on administrative data precluded us from investigating appropriateness in this study, but this is certainly an area for further investigation.
We observed that a substantially smaller percentage of Ontario hospitals offered TJA, and those that offered TJA had significantly higher procedural volumes compared to New York hospitals; this likely reflects differences in the regulatory environment. Ontario-like many single-payor systems with substantial government involvement-relies on centralized planning to determine which hospitals should offer which services (38, 39) . In the US, hospitals are encouraged to be entrepreneurial, with the idea that competition breeds lower price and higher quality; hospitals are typically able to offer most clinical services with minimal regulatory barriers. Moreover, in the US, TJA is typically thought to be profitable for hospitals (7) . Thus, it is not surprising that the percentage of hospitals performing TJA in New York is far higher but the procedural volumes are substantially lower when compared to Ontario.
It is important to address the differences in outcomes that we observed. Patients in Ontario were much more likely to be discharged home and much less likely to be discharged to post-acute care (e.g., inpatient rehabilitation) when compared to patients in New York. Post-acute care is expensive, and supply in Ontario is extremely limited, making discharge home the preferred option (40) . In contrast, post-acute care in the US is typically available and covered by insurance, making it easy for hospitals to discharge patients to rehabilitation. It is noteworthy that even with~90% of Ontario patients discharged home after TJA, hospital readmission rates were actually lower than in New York. The combination of lower utilization of post-acute care in Ontario and lower readmission rates suggests that there are still significant efficiencies to be gained in the US (41, 42) . A number of other findings warrant brief mention. We would be remiss if we did not speak to the differences in comorbidity that we observed. One possible explanation would be that TKA and THA recipients in New York truly have prevalence rates of heart failure, hypertension, and diabetes that are markedly higher than in Ontario; this seems implausible. Rather, we suspect that the wellrecognized pressure to "up-code" for purposes of reimbursement and risk adjustment is the major driver of the differences observed (43, 44) . If differences in comorbidity reflect cross-border differences in coding practices rather than true differences in the prevalence of comorbid conditions, adjustment for such comorbidities could introduce major bias into risk-adjustment models.
It is important to point out limitations in our study. Our analysis was limited to patients in Ontario, Canada and the state of New York; generalizing our findings to the entire country of Canada and the entire US should be done with caution, particularly given the marked differences in health care delivery across Canada's different provinces.
Furthermore, our study relied on hospital administrative data and lacked reliable information on comorbidities, and we were unable to assess data on patientreported outcomes and long-term follow-up. In addition, we were unable to exclude unicompartmental procedures from our TKA cohort because the granularity of ICD-9 coding is limited, and unicompartmental procedures represent~10% of knee arthroplasty procedures (45, 46) . We included unicompartmental procedures in both our New York cohorts and our Ontario cohorts to avoid biasing our results.
Finally, we are unable to comment on the indications for each procedure or their clinical appropriateness (36, 47, 48) . Thus, although utilization in Ontario was greater than that in New York, we are unable to say whether higher TJA utilization represents underuse in New York or overuse in Ontario.
In summary, we found higher utilization of TJA in Ontario than in New York, but evidence of greater efficiency (e.g., higher hospital volumes and lower readmission rates) in Ontario. Taken together, our results hint at opportunities for further improvement in each locale.
